Details of the Drug Combinations

General Information of This Drug (ID: DMG2YBD)

Drug Name
Trifluridine   DMG2YBD
Synonyms
Fluridine; TFDU; TRIFLUOROTHYMIDINE; Trifluoridine; Trifluoromethyldeoxyuridine; Trifluridina; Trifluridinum; Virophta; Viroptic; Trifluorothymine deoxyriboside; CF3dUrd; F3DThd; F3T; F3TDR; HS-0007; Trifluridina [INN-Spanish]; Trifluridine [USAN:INN]; Trifluridinum [INN-Latin]; Viroptic (TN); Trifluridine (USP/INN);Viroptic, Trifluorothymidine, Trifluridine; Alpha,alpha,alpha-Trifluorothymidine; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione; 2'-Deoxy-5-(trifluoromethyl)uridine; 2'-Deoxy-5-trifluoromethyluridine; 5-(Trifluoromethyl)-2'-deoxyuridine; 5-(Trifluoromethyl)deoxyuridine; 5-Trifluoro-2'-deoxythymidine; 5-Trifluoromethyl-2'-deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; 5-Trifluorothymidine
Indication
Disease Entry ICD 11 Status REF
Herpetic keratitis 1F00.10 Approved [1]
Virus infection 1A24-1D9Z Approved [2]
Colon cancer 2B90.Z Investigative [1]
Therapeutic Class
Antiviral Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

485 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Trifluridine DCVMKL1 ABIRATERONE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
ABIRATERONE + Trifluridine DC780IS ABIRATERONE Astrocytoma (Cell Line: SNB-19) [3]
ABIRATERONE + Trifluridine DCNV2GV ABIRATERONE Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
ABIRATERONE + Trifluridine DCGD64K ABIRATERONE Plasma cell myeloma (Cell Line: RPMI-8226) [3]
ABIRATERONE + Trifluridine DCISU6Y ABIRATERONE Renal cell carcinoma (Cell Line: SN12C) [3]
ABIRATERONE + Trifluridine DC15MK8 ABIRATERONE Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
ABIRATERONE + Trifluridine DC1BWT9 ABIRATERONE Colon carcinoma (Cell Line: KM12) [4]
ABIRATERONE + Trifluridine DC3H05B ABIRATERONE Adenocarcinoma (Cell Line: SW-620) [5]
ABIRATERONE + Trifluridine DCJSJW1 ABIRATERONE Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
ABIRATERONE + Trifluridine DCADM2T ABIRATERONE Lung adenocarcinoma (Cell Line: HOP-62) [5]
ABIRATERONE + Trifluridine DCQVJIF ABIRATERONE Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Anastrozole + Trifluridine DC4AAQ3 Anastrozole Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Trifluridine DCSNXUF Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Trifluridine DCQKJHS Anastrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Trifluridine DC498MM Anastrozole Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Trifluridine DCI0626 Anastrozole Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Trifluridine DCWAO56 Anastrozole Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Trifluridine DC8CFQS Anastrozole Glioma (Cell Line: SF-539) [3]
Anastrozole + Trifluridine DCXFRL9 Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Trifluridine DCOI2Z2 Anastrozole Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Trifluridine DCLL19J Anastrozole Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Trifluridine DCI0L1B Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Trifluridine DC63BSC Anastrozole Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Trifluridine DCONKZC Anastrozole Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Trifluridine DC06727 Anastrozole Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Trifluridine DC8XJ9R Anastrozole Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Trifluridine DCTUQZJ Anastrozole Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Trifluridine DCM74A9 Anastrozole Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Anastrozole + Trifluridine DCK29XP Anastrozole Colon carcinoma (Cell Line: KM12) [4]
Anastrozole + Trifluridine DC6SD5V Anastrozole Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Cabazitaxel + Trifluridine DCN331L Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [3]
Cabazitaxel + Trifluridine DCS6Y18 Cabazitaxel Adenocarcinoma (Cell Line: HT29) [3]
Cabazitaxel + Trifluridine DC6A9S5 Cabazitaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Cabazitaxel + Trifluridine DCYZQP6 Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Cabazitaxel + Trifluridine DCS9JV2 Cabazitaxel Astrocytoma (Cell Line: SNB-19) [3]
Cabazitaxel + Trifluridine DC53PNM Cabazitaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Cabazitaxel + Trifluridine DCBOB6N Cabazitaxel Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Cabazitaxel + Trifluridine DCJKPGS Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Cabazitaxel + Trifluridine DCSPITM Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Cabazitaxel + Trifluridine DC5KG9S Cabazitaxel Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Cabazitaxel + Trifluridine DCQ7V9R Cabazitaxel Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Cabazitaxel + Trifluridine DC1PW5R Cabazitaxel Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Cabazitaxel + Trifluridine DCOMNFG Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [3]
Cabazitaxel + Trifluridine DC6NGHG Cabazitaxel Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Cabazitaxel + Trifluridine DC2G4L9 Cabazitaxel Carcinoma (Cell Line: RXF 393) [4]
Cabazitaxel + Trifluridine DCJJI40 Cabazitaxel Invasive ductal carcinoma (Cell Line: T-47D) [4]
Cabazitaxel + Trifluridine DC4JTYP Cabazitaxel Invasive ductal carcinoma (Cell Line: BT-549) [4]
Cabazitaxel + Trifluridine DCLRIBS Cabazitaxel Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Crizotinib + Trifluridine DCZEN8S Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Crizotinib + Trifluridine DC8PW5T Crizotinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Crizotinib + Trifluridine DC0EVHW Crizotinib Astrocytoma (Cell Line: SNB-19) [3]
Crizotinib + Trifluridine DCUIVOY Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Crizotinib + Trifluridine DC1OZSS Crizotinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Crizotinib + Trifluridine DCYR0AK Crizotinib Renal cell carcinoma (Cell Line: SN12C) [3]
Crizotinib + Trifluridine DCV8JU2 Crizotinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Epirubicin + Trifluridine DCU3Y8P Epirubicin Glioma (Cell Line: SF-539) [3]
Epirubicin + Trifluridine DCEIUUR Epirubicin Renal cell carcinoma (Cell Line: SN12C) [3]
Epirubicin + Trifluridine DCH94DJ Epirubicin Colon carcinoma (Cell Line: KM12) [4]
Epirubicin + Trifluridine DCBYC3V Epirubicin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Gefitinib + Trifluridine DCQGY3B Gefitinib Adenocarcinoma (Cell Line: SW-620) [3]
Gefitinib + Trifluridine DCTIFG1 Gefitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Gefitinib + Trifluridine DCP3C5W Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Gefitinib + Trifluridine DCHZ8FH Gefitinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Gefitinib + Trifluridine DCUE28R Gefitinib Glioma (Cell Line: SF-539) [3]
Gefitinib + Trifluridine DCZNDGQ Gefitinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Gefitinib + Trifluridine DCAPY99 Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Gefitinib + Trifluridine DCSRF4B Gefitinib Prostate carcinoma (Cell Line: PC-3) [3]
Gefitinib + Trifluridine DCO30JH Gefitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Indazole derivative 5 + Trifluridine DCIKOE3 Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Indazole derivative 5 + Trifluridine DC2SGLA Indazole derivative 5 Astrocytoma (Cell Line: SNB-19) [3]
Indazole derivative 5 + Trifluridine DCYYMBG Indazole derivative 5 Glioma (Cell Line: SF-539) [3]
Indazole derivative 5 + Trifluridine DC78RPH Indazole derivative 5 Renal cell carcinoma (Cell Line: SN12C) [3]
Indazole derivative 5 + Trifluridine DCUIGXT Indazole derivative 5 Colon carcinoma (Cell Line: KM12) [4]
Indazole derivative 5 + Trifluridine DC3YSO9 Indazole derivative 5 Invasive ductal carcinoma (Cell Line: T-47D) [4]
Indazole derivative 5 + Trifluridine DCNC60R Indazole derivative 5 Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Indazole derivative 5 + Trifluridine DC0WG0B Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Indazole derivative 5 + Trifluridine DCY35VT Indazole derivative 5 Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Lenalidomide + Trifluridine DC3JIF7 Lenalidomide Lung adenocarcinoma (Cell Line: HOP-62) [5]
Ruxolitinib + Trifluridine DC9ZTDE Ruxolitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Ruxolitinib + Trifluridine DC1RPQY Ruxolitinib Renal cell carcinoma (Cell Line: SN12C) [3]
Ruxolitinib + Trifluridine DCIR29V Ruxolitinib Colon carcinoma (Cell Line: KM12) [4]
Ruxolitinib + Trifluridine DC2P348 Ruxolitinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Ruxolitinib + Trifluridine DCYOGCK Ruxolitinib Adenocarcinoma (Cell Line: SW-620) [5]
Trifluridine + Mechlorethamine DC4J5ED Mechlorethamine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Fulvestrant DCS7ZQE Fulvestrant Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Trifluridine + Hepzato DC4F8X6 Hepzato Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Trifluridine + Ixabepilone DCXR9I8 Ixabepilone Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Trifluridine + Ixabepilone DCSZHBA Ixabepilone Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Ixabepilone DC8EUKD Ixabepilone Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Trifluridine + Ixabepilone DC85KBL Ixabepilone Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Trifluridine + Ixabepilone DCE232J Ixabepilone Glioblastoma (Cell Line: SNB-75) [3]
Trifluridine + Ixabepilone DC16VQP Ixabepilone Glioma (Cell Line: SF-295) [3]
Trifluridine + Dactinomycin DC3ES2Q Dactinomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Dactinomycin DCD6CY1 Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Trifluridine + Dactinomycin DC3AY1B Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Dactinomycin DCQP057 Dactinomycin Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Dactinomycin DCRWKV8 Dactinomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Trifluridine + Dactinomycin DCAH70N Dactinomycin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Trifluridine + Dactinomycin DCDSXB3 Dactinomycin Glioblastoma (Cell Line: SNB-75) [3]
Trifluridine + Dactinomycin DCKYSRL Dactinomycin Glioma (Cell Line: SF-295) [3]
Trifluridine + Dactinomycin DC7E7NX Dactinomycin Glioma (Cell Line: SF-268) [3]
Trifluridine + Dactinomycin DCT7RAJ Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Trifluridine + Dactinomycin DCY56W5 Dactinomycin Renal cell carcinoma (Cell Line: UO-31) [3]
Trifluridine + DFN-15 DC0NF83 DFN-15 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Trifluridine + PMID28460551-Compound-2 DCLFBO8 PMID28460551-Compound-2 Glioma (Cell Line: SF-268) [3]
Trifluridine + PMID28460551-Compound-2 DCRTG64 PMID28460551-Compound-2 Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Trifluridine + Crizotinib DC170GS Crizotinib Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Cyclophosphamide DCRMQDE Cyclophosphamide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + LIAROZOLE DC41ZAI LIAROZOLE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + LIAROZOLE DC8PSS5 LIAROZOLE Clear cell renal cell carcinoma (Cell Line: A498) [3]
Trifluridine + LIAROZOLE DCUP182 LIAROZOLE Glioma (Cell Line: SF-268) [3]
Trifluridine + Isoniazid DCQNV1Z Isoniazid Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Isoniazid DC7H53D Isoniazid Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Trifluridine + Arsenic trioxide DC7730D Arsenic trioxide Astrocytoma (Cell Line: U251) [3]
Trifluridine + Vemurafenib DC4TN6I Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Trifluridine + Plicamycin DCS6CND Plicamycin Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Nilotinib DCQF591 Nilotinib Glioma (Cell Line: SF-295) [3]
Trifluridine + Thioguanine DCNOB48 Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Thioguanine DCSK2FP Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Thioguanine DCKNRZ6 Thioguanine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Trifluridine + Triapine DC17SMO Triapine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Triapine DCFGQVO Triapine Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Trifluridine + Triapine DCJ7SY2 Triapine Clear cell renal cell carcinoma (Cell Line: A498) [3]
Trifluridine + 10-hydroxycamptothecin DC3XMGX 10-hydroxycamptothecin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Topetecan DCCNZFQ Topetecan Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Trifluridine + Topetecan DCG12SZ Topetecan Glioma (Cell Line: SF-295) [3]
Trifluridine + Amonafide DC1I83B Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Pralatrexate DCY946Z Pralatrexate Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Pralatrexate DCZ0K1O Pralatrexate Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Trifluridine + Pralatrexate DCLCJVI Pralatrexate Glioma (Cell Line: SF-295) [3]
Trifluridine + Pralatrexate DCNVBID Pralatrexate Renal cell carcinoma (Cell Line: SN12C) [3]
Trifluridine + Ifosfamide DCSRRE1 Ifosfamide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Ifosfamide DC818ZI Ifosfamide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Trifluridine + Ifosfamide DC3NSWC Ifosfamide Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Trifluridine + Dexrazoxane DCE2197 Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Dexrazoxane DCC416F Dexrazoxane Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Trifluridine + Dexrazoxane DCEL3FW Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Dexrazoxane DCSZA1A Dexrazoxane Chronic myelogenous leukemia (Cell Line: K-562) [3]
Trifluridine + Dexrazoxane DCGC7EZ Dexrazoxane Glioma (Cell Line: SF-268) [3]
Trifluridine + Dexrazoxane DCFB0W6 Dexrazoxane Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Trifluridine + Docetaxel DCTS7ZO Docetaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Trifluridine + Docetaxel DC8OY5Q Docetaxel Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Trifluridine + Raloxifene DCIY7BJ Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Raloxifene DCEL76M Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Trifluridine + Marizomib DCG6NWS Marizomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Trifluridine + Bendamustine hydrochloride DCXYEUB Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Trifluridine + Bendamustine hydrochloride DCHL8DC Bendamustine hydrochloride Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Bendamustine hydrochloride DC29K16 Bendamustine hydrochloride Chronic myelogenous leukemia (Cell Line: K-562) [3]
Trifluridine + Bendamustine hydrochloride DCLBH0L Bendamustine hydrochloride Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Trifluridine + Mitomycin DCZK81K Mitomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Mitomycin DC1EBH0 Mitomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Mitomycin DCRS6P7 Mitomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Trifluridine + Mitomycin DCBZ0F8 Mitomycin Glioma (Cell Line: SF-268) [3]
Trifluridine + Mitomycin DC9QPVJ Mitomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Trifluridine + SY-1425 DCDT531 SY-1425 Glioma (Cell Line: SF-539) [3]
Trifluridine + SY-1425 DCPGK7B SY-1425 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Trifluridine + Uracil mustard DC39HU4 Uracil mustard Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Uracil mustard DCNHSY6 Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Uracil mustard DCADJ6I Uracil mustard Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Trifluridine + Uracil mustard DCKJWN7 Uracil mustard Glioma (Cell Line: SF-295) [3]
Trifluridine + Vincristine DC2YTOB Vincristine Clear cell renal cell carcinoma (Cell Line: A498) [3]
Trifluridine + Arfolitixorin DCI7Y1Y Arfolitixorin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + BIO-300 DCY7ZHX BIO-300 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + BIO-300 DCL6AJQ BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [3]
Trifluridine + BIO-300 DC0OHGJ BIO-300 Glioma (Cell Line: SF-268) [3]
Trifluridine + Idarubicin DCLMY4A Idarubicin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Bleomycin DC4YQ6A Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Bleomycin DCN0IS6 Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Trifluridine + Bleomycin DCY29QR Bleomycin Astrocytoma (Cell Line: U251) [3]
Trifluridine + Bleomycin DCJ7TKD Bleomycin Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Bleomycin DCCO7R5 Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Trifluridine + Bleomycin DCTA1ML Bleomycin Glioma (Cell Line: SF-539) [3]
Trifluridine + Bleomycin DC74FDF Bleomycin Glioma (Cell Line: SF-268) [3]
Trifluridine + Bleomycin DC3EYMP Bleomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Trifluridine + Bortezomib DCLHEGY Bortezomib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Trifluridine + Bortezomib DC4DYWC Bortezomib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Trifluridine + Bortezomib DCMMI8M Bortezomib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Trifluridine + Topotecan DCIS98T Topotecan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Topotecan DCX7OOH Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Trifluridine + Topotecan DCQU7QP Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Trifluridine + Topotecan DCNGG9H Topotecan Glioblastoma (Cell Line: SNB-75) [3]
Trifluridine + Cisplatin DCS7Q57 Cisplatin Astrocytoma (Cell Line: U251) [3]
Trifluridine + Chlorambucil DC91VF2 Chlorambucil Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Sorafenib DC7BWXB Sorafenib Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + ER819762 DCNZSLT ER819762 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + ER819762 DCSL234 ER819762 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Trifluridine + Azacitidine DCTB1ZI Azacitidine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Azacitidine DC3HP20 Azacitidine Astrocytoma (Cell Line: U251) [3]
Trifluridine + Azacitidine DCJ3FUC Azacitidine Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Azacitidine DCHEQNK Azacitidine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Trifluridine + Pomalidomide DCRX58I Pomalidomide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Vinflunine DCPCD6O Vinflunine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Mercaptopurine DCIGPG9 Mercaptopurine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Mercaptopurine DC11KOG Mercaptopurine Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Mepacrine DCTJAN8 Mepacrine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Fludarabine DCHME68 Fludarabine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Trifluridine + PMID28870136-Compound-43 DCH9A6F PMID28870136-Compound-43 Clear cell renal cell carcinoma (Cell Line: A498) [3]
Trifluridine + FORMESTANE DC79BFX FORMESTANE Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Trifluridine + Aminolevulinic Acid Hydrochloride DCBWM3I Aminolevulinic Acid Hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Aminolevulinic Acid Hydrochloride DCPUWBB Aminolevulinic Acid Hydrochloride Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Trifluridine + Aminolevulinic Acid Hydrochloride DCIKBT9 Aminolevulinic Acid Hydrochloride Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Trifluridine + Aminolevulinic Acid Hydrochloride DCCJVVR Aminolevulinic Acid Hydrochloride Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Trifluridine + Estramustine DCSKDFL Estramustine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Trifluridine + Estramustine DCL14JJ Estramustine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Estramustine DC1GDUM Estramustine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Trifluridine + Digitoxin DC99OBA Digitoxin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Digitoxin DCLGIQG Digitoxin Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Digitoxin DCVX6T8 Digitoxin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Trifluridine + Busulfan DCTUQAX Busulfan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Busulfan DCTUEWS Busulfan Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Trifluridine + Ibrutinib DCE1YBQ Ibrutinib Diffuse large B cell lymphoma (Cell Line: TMD8) [3]
Trifluridine + Dasatinib DCY9KQ0 Dasatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Trifluridine + Dasatinib DCR2CVS Dasatinib Glioma (Cell Line: SF-539) [3]
Trifluridine + Dasatinib DC6V8F3 Dasatinib Glioma (Cell Line: SF-295) [3]
Trifluridine + Mechlorethamine DC23Y6S Mechlorethamine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Trifluridine + Ixabepilone DC5W2G7 Ixabepilone Carcinoma (Cell Line: MCF7) [4]
Trifluridine + Dactinomycin DCQJUG9 Dactinomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + Dactinomycin DC9YU1L Dactinomycin Carcinoma (Cell Line: RXF 393) [4]
Trifluridine + Dactinomycin DCAL5N9 Dactinomycin Carcinoma (Cell Line: MCF7) [4]
Trifluridine + Dactinomycin DC6WOMM Dactinomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Trifluridine + Dactinomycin DC3V6J8 Dactinomycin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Trifluridine + Dactinomycin DCFB3MA Dactinomycin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Trifluridine + Dactinomycin DC9K1EX Dactinomycin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Trifluridine + PMID28460551-Compound-2 DCA1R0Q PMID28460551-Compound-2 Colon adenocarcinoma (Cell Line: COLO 205) [4]
Trifluridine + Isoniazid DCGI3NO Isoniazid Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Trifluridine + Arsenic trioxide DCU9BM4 Arsenic trioxide Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + Plicamycin DCPKJZ0 Plicamycin Carcinoma (Cell Line: RXF 393) [4]
Trifluridine + Plicamycin DCWDGZ2 Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Trifluridine + Thioguanine DCU0WIH Thioguanine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + Triapine DC5VSL8 Triapine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + Amonafide DCGTZSX Amonafide Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + Amonafide DCUIT46 Amonafide Colon carcinoma (Cell Line: KM12) [4]
Trifluridine + Pralatrexate DC1CX9H Pralatrexate Carcinoma (Cell Line: MCF7) [4]
Trifluridine + Terameprocol DCRYNG8 Terameprocol Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + Terameprocol DCVL2L2 Terameprocol Colon adenocarcinoma (Cell Line: COLO 205) [4]
Trifluridine + Ifosfamide DC8MD73 Ifosfamide Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Trifluridine + Dexrazoxane DCKSNCW Dexrazoxane Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + Dexrazoxane DC5QVSI Dexrazoxane Colon adenocarcinoma (Cell Line: COLO 205) [4]
Trifluridine + Bendamustine hydrochloride DCOJ6RO Bendamustine hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [4]
Trifluridine + Sirolimus DC54LBB Sirolimus Colon adenocarcinoma (Cell Line: COLO 205) [4]
Trifluridine + Mitomycin DC6KEXL Mitomycin Carcinoma (Cell Line: RXF 393) [4]
Trifluridine + Mitomycin DC3SDQU Mitomycin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Trifluridine + SY-1425 DCSBDF5 SY-1425 Carcinoma (Cell Line: MCF7) [4]
Trifluridine + Uracil mustard DCM7XQ4 Uracil mustard Colon carcinoma (Cell Line: KM12) [4]
Trifluridine + Arfolitixorin DC65JCJ Arfolitixorin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + BIO-300 DC0ZR6E BIO-300 Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + BIO-300 DCINT2H BIO-300 Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Trifluridine + Imatinib DCWI7AF Imatinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Trifluridine + Bleomycin DCI1SOY Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + Bleomycin DCTCRIR Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Trifluridine + Bleomycin DCNYE51 Bleomycin Colon carcinoma (Cell Line: KM12) [4]
Trifluridine + Bleomycin DCUF5SM Bleomycin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Trifluridine + Bleomycin DC36LMH Bleomycin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Trifluridine + Bleomycin DCGRARS Bleomycin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Trifluridine + Bortezomib DC9YYLJ Bortezomib Carcinoma (Cell Line: MCF7) [4]
Trifluridine + Topotecan DC9DMAX Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Trifluridine + Chlorambucil DCCJAHI Chlorambucil Invasive ductal carcinoma (Cell Line: T-47D) [4]
Trifluridine + Romidepsin DC1M1LW Romidepsin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Trifluridine + Azacitidine DCISMCW Azacitidine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + Mepacrine DCSRHJU Mepacrine Colon carcinoma (Cell Line: KM12) [4]
Trifluridine + PMID28870136-Compound-43 DCWOS7C PMID28870136-Compound-43 Invasive ductal carcinoma (Cell Line: T-47D) [4]
Trifluridine + Busulfan DC81FC0 Busulfan Invasive ductal carcinoma (Cell Line: T-47D) [4]
Trifluridine + Mechlorethamine DCKMRID Mechlorethamine Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + Fulvestrant DCL0Y3D Fulvestrant Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + Hepzato DC8E2VG Hepzato Adenocarcinoma (Cell Line: DU-145) [5]
Trifluridine + Hepzato DCNY7N1 Hepzato Prostate carcinoma (Cell Line: PC-3) [5]
Trifluridine + Ixabepilone DCWXHKQ Ixabepilone Adenocarcinoma (Cell Line: DU-145) [5]
Trifluridine + Ixabepilone DC52AQ9 Ixabepilone Adenocarcinoma (Cell Line: OVCAR3) [5]
Trifluridine + Ixabepilone DCPBLNE Ixabepilone Adenocarcinoma (Cell Line: HCC-2998) [5]
Trifluridine + Ixabepilone DCM2DXB Ixabepilone Adenocarcinoma (Cell Line: HCT116) [5]
Trifluridine + Ixabepilone DCKYIN9 Ixabepilone Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Trifluridine + Ixabepilone DCAXZPN Ixabepilone Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + Ixabepilone DCH44JL Ixabepilone Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + Ixabepilone DC6P14Y Ixabepilone Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Ixabepilone DCJ5Y1O Ixabepilone Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Trifluridine + Ixabepilone DCX07QI Ixabepilone Prostate carcinoma (Cell Line: PC-3) [5]
Trifluridine + Dactinomycin DCVJV33 Dactinomycin Adenocarcinoma (Cell Line: HCT-15) [5]
Trifluridine + Dactinomycin DC9X8UX Dactinomycin Adenocarcinoma (Cell Line: HCT116) [5]
Trifluridine + Dactinomycin DCD21RC Dactinomycin Adenocarcinoma (Cell Line: SW-620) [5]
Trifluridine + Dactinomycin DC8028I Dactinomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Trifluridine + Dactinomycin DCCUA30 Dactinomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Trifluridine + Dactinomycin DCE2PZ4 Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Trifluridine + Dactinomycin DCOCGKP Dactinomycin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Trifluridine + Dactinomycin DCGQBLD Dactinomycin Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Dactinomycin DCEVL8U Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Trifluridine + Dactinomycin DCKV2VV Dactinomycin Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + Dactinomycin DCH8RBI Dactinomycin Melanoma (Cell Line: SK-MEL-2) [5]
Trifluridine + Dactinomycin DCM8FUJ Dactinomycin Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + Dactinomycin DC1GULX Dactinomycin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Dactinomycin DCBG6V2 Dactinomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Trifluridine + Dactinomycin DC1HPMR Dactinomycin Prostate carcinoma (Cell Line: PC-3) [5]
Trifluridine + DFN-15 DCJ4OZA DFN-15 Adenocarcinoma (Cell Line: SW-620) [5]
Trifluridine + DFN-15 DCG6GEQ DFN-15 Lung adenocarcinoma (Cell Line: HOP-62) [5]
Trifluridine + Lapatinib DCEZ8HA Lapatinib Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + Lapatinib DCUD2AQ Lapatinib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Trifluridine + Lapatinib DCGCSIS Lapatinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Lapatinib DC88WBS Lapatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Trifluridine + PMID28460551-Compound-2 DCOXTAZ PMID28460551-Compound-2 Adenocarcinoma (Cell Line: A549) [5]
Trifluridine + PMID28460551-Compound-2 DC3BV00 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HT29) [5]
Trifluridine + PMID28460551-Compound-2 DC9JSC2 PMID28460551-Compound-2 Amelanotic melanoma (Cell Line: M14) [5]
Trifluridine + PMID28460551-Compound-2 DCQEXR0 PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + PMID28460551-Compound-2 DCODEF4 PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: HOP-62) [5]
Trifluridine + PMID28460551-Compound-2 DCDG12V PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Trifluridine + PMID28460551-Compound-2 DCHJ2N5 PMID28460551-Compound-2 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + PMID28460551-Compound-2 DCE320E PMID28460551-Compound-2 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Trifluridine + PMID28460551-Compound-2 DCPP7OF PMID28460551-Compound-2 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Trifluridine + Crizotinib DCHQUAN Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Trifluridine + Crizotinib DCWR8TX Crizotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Crizotinib DCV1VWJ Crizotinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Trifluridine + Cyclophosphamide DC0HAA7 Cyclophosphamide Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + LIAROZOLE DCLWDFF LIAROZOLE Adenocarcinoma (Cell Line: HT29) [5]
Trifluridine + LIAROZOLE DC51K0G LIAROZOLE Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + LIAROZOLE DC2CKS0 LIAROZOLE Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Trifluridine + Methotrexate DCR3KYR Methotrexate Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Isoniazid DC8O6DY Isoniazid Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Arsenic trioxide DCAUCJW Arsenic trioxide Adenocarcinoma (Cell Line: HT29) [5]
Trifluridine + Arsenic trioxide DCLXNOC Arsenic trioxide Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Trifluridine + Arsenic trioxide DCUMLUM Arsenic trioxide Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Arsenic trioxide DCI1Q3F Arsenic trioxide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Trifluridine + Vemurafenib DCH516M Vemurafenib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Plicamycin DCR8NCW Plicamycin Adenocarcinoma (Cell Line: SW-620) [5]
Trifluridine + Plicamycin DCUGX7I Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Trifluridine + Plicamycin DCMO0HP Plicamycin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Trifluridine + Nilotinib DCI9HBW Nilotinib Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + Nilotinib DCQ4K7G Nilotinib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Trifluridine + Nilotinib DCQ7S7H Nilotinib Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + Nilotinib DCVU9SI Nilotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Nilotinib DCPP4UR Nilotinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Trifluridine + Triapine DCJ1ZEV Triapine Adenocarcinoma (Cell Line: A549) [5]
Trifluridine + Triapine DCVE9FB Triapine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Trifluridine + Triapine DCSSGRY Triapine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Trifluridine + Triapine DCPHD7Z Triapine Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Triapine DCLA67N Triapine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Trifluridine + Triapine DC2ZJRH Triapine Prostate carcinoma (Cell Line: PC-3) [5]
Trifluridine + 10-hydroxycamptothecin DC9OA40 10-hydroxycamptothecin Adenocarcinoma (Cell Line: HT29) [5]
Trifluridine + 10-hydroxycamptothecin DCVF2XT 10-hydroxycamptothecin Amelanotic melanoma (Cell Line: M14) [5]
Trifluridine + Topetecan DCO39F1 Topetecan Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Topetecan DCNAZV1 Topetecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Amonafide DCRA8JJ Amonafide Lung adenocarcinoma (Cell Line: HOP-62) [5]
Trifluridine + Amonafide DC2MBPY Amonafide Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + Pralatrexate DC45BCD Pralatrexate Adenocarcinoma (Cell Line: OVCAR3) [5]
Trifluridine + Pralatrexate DCS7MZU Pralatrexate Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + Pralatrexate DCPEG4L Pralatrexate Adenocarcinoma (Cell Line: HCT-15) [5]
Trifluridine + Pralatrexate DCB01JO Pralatrexate High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Trifluridine + Pralatrexate DCMUZ35 Pralatrexate Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Pralatrexate DCHPKY9 Pralatrexate Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Trifluridine + Pralatrexate DCCRGN6 Pralatrexate Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Trifluridine + Terameprocol DCJ8K5K Terameprocol Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + Terameprocol DCA4DR4 Terameprocol Adenocarcinoma (Cell Line: HCT116) [5]
Trifluridine + SCH 727965 DC7BLDV SCH 727965 Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + SCH 727965 DCZZPXZ SCH 727965 Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Trifluridine + SCH 727965 DCVI7EK SCH 727965 Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + SCH 727965 DC9E70U SCH 727965 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + SCH 727965 DCH6AF7 SCH 727965 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Trifluridine + SCH 727965 DCARRL4 SCH 727965 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Trifluridine + Ifosfamide DCYCJI4 Ifosfamide Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Trifluridine + Dexrazoxane DCMPP1M Dexrazoxane Adenocarcinoma (Cell Line: SW-620) [5]
Trifluridine + Dexrazoxane DCXHZOM Dexrazoxane Lung adenocarcinoma (Cell Line: HOP-62) [5]
Trifluridine + Dexrazoxane DCGDW6F Dexrazoxane Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + Dexrazoxane DCLDLZW Dexrazoxane Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Trifluridine + Docetaxel DCC6KO4 Docetaxel Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Bendamustine hydrochloride DCCEOWY Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [5]
Trifluridine + Bendamustine hydrochloride DC5VYZV Bendamustine hydrochloride Adenocarcinoma (Cell Line: SW-620) [5]
Trifluridine + Bendamustine hydrochloride DC35VZ3 Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT-15) [5]
Trifluridine + Bendamustine hydrochloride DCWKKVY Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [5]
Trifluridine + Bendamustine hydrochloride DCJZG1Q Bendamustine hydrochloride Adenocarcinoma (Cell Line: HT29) [5]
Trifluridine + Bendamustine hydrochloride DCNCPRC Bendamustine hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Trifluridine + Bendamustine hydrochloride DCZTP1U Bendamustine hydrochloride Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + Letrozole DC3B0OR Letrozole Adenocarcinoma (Cell Line: DU-145) [5]
Trifluridine + Letrozole DCOABR4 Letrozole Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Trifluridine + Mitomycin DC34HSL Mitomycin Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + Mitomycin DCZV2AZ Mitomycin Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Mitomycin DC96THB Mitomycin Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + Mitomycin DCFV1SP Mitomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Trifluridine + Mitomycin DCETKAR Mitomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Trifluridine + SY-1425 DCCR74V SY-1425 Adenocarcinoma (Cell Line: HT29) [5]
Trifluridine + SY-1425 DC906SI SY-1425 Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Uracil mustard DCT7NR5 Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Trifluridine + Uracil mustard DC1I0MX Uracil mustard Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + Vincristine DCRD3AF Vincristine Adenocarcinoma (Cell Line: A549) [5]
Trifluridine + Vincristine DC0FFX2 Vincristine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Trifluridine + Arfolitixorin DCWEY7M Arfolitixorin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Trifluridine + BIO-300 DCSM3DO BIO-300 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Trifluridine + BIO-300 DC1O710 BIO-300 Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + TEM DCJZWC5 TEM Adenocarcinoma (Cell Line: SW-620) [5]
Trifluridine + JNK-IN-8 DC1VCKH JNK-IN-8 Adenocarcinoma (Cell Line: HT29) [5]
Trifluridine + Idarubicin DCUYPYZ Idarubicin Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Idarubicin DCBWAJ9 Idarubicin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Trifluridine + Imatinib DC9FKWD Imatinib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Trifluridine + Imatinib DC83XHG Imatinib Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + Imatinib DC4O7TX Imatinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Imatinib DCQTG1I Imatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Trifluridine + Bleomycin DCHIW65 Bleomycin Adenocarcinoma (Cell Line: SW-620) [5]
Trifluridine + Bleomycin DCAKXNZ Bleomycin Adenocarcinoma (Cell Line: HT29) [5]
Trifluridine + Bleomycin DCVR5FD Bleomycin Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Bleomycin DCOJW22 Bleomycin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Trifluridine + Bleomycin DCPS8H3 Bleomycin Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + Bleomycin DCQV08B Bleomycin Melanoma (Cell Line: UACC-257) [5]
Trifluridine + Bleomycin DCZ8SM2 Bleomycin Melanoma (Cell Line: SK-MEL-2) [5]
Trifluridine + Bleomycin DC4ZWJU Bleomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Trifluridine + Bortezomib DC8DYUM Bortezomib Adenocarcinoma (Cell Line: OVCAR3) [5]
Trifluridine + Bortezomib DCVP6WQ Bortezomib Adenocarcinoma (Cell Line: HT29) [5]
Trifluridine + Bortezomib DC1W423 Bortezomib Adenocarcinoma (Cell Line: HCT-15) [5]
Trifluridine + Bortezomib DCSGO5M Bortezomib Adenocarcinoma (Cell Line: HCC-2998) [5]
Trifluridine + Bortezomib DCARFOE Bortezomib Amelanotic melanoma (Cell Line: M14) [5]
Trifluridine + Bortezomib DC4PO0Q Bortezomib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Trifluridine + Bortezomib DCQWZY4 Bortezomib Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + Bortezomib DCH1QH3 Bortezomib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Bortezomib DCR0TWN Bortezomib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Trifluridine + Valrubicin DCZLFMU Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Trifluridine + Valrubicin DCTHFAA Valrubicin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Trifluridine + Valrubicin DC4QXY6 Valrubicin Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + Topotecan DCFZHPF Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Trifluridine + Topotecan DC908FG Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Trifluridine + Topotecan DCV3TA5 Topotecan Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Topotecan DC78DT8 Topotecan Melanoma (Cell Line: UACC-257) [5]
Trifluridine + Topotecan DCTIP5W Topotecan Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + Topotecan DCGHFEW Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Cisplatin DCPNE5D Cisplatin Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + Chlorambucil DCOIIXF Chlorambucil Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + Chlorambucil DCYI9HA Chlorambucil Adenocarcinoma (Cell Line: HCT116) [5]
Trifluridine + Chlorambucil DCGX37L Chlorambucil Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Chlorambucil DCRAJGJ Chlorambucil Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Sorafenib DCBC0SW Sorafenib Adenocarcinoma (Cell Line: DU-145) [5]
Trifluridine + Sorafenib DCSELCY Sorafenib Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + Sorafenib DCNTPHG Sorafenib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Trifluridine + Sorafenib DCHTTTK Sorafenib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Sorafenib DCK1CRX Sorafenib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Trifluridine + ER819762 DCV5LYB ER819762 Adenocarcinoma (Cell Line: DU-145) [5]
Trifluridine + ER819762 DCB86EY ER819762 Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + ER819762 DCV9ELQ ER819762 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Romidepsin DC8C7Z3 Romidepsin Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Trifluridine + Romidepsin DC4T9TN Romidepsin Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + Romidepsin DC04BQG Romidepsin Melanoma (Cell Line: UACC-257) [5]
Trifluridine + Romidepsin DCT6LU1 Romidepsin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Romidepsin DCT65RS Romidepsin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Trifluridine + Azacitidine DCGK85U Azacitidine Adenocarcinoma (Cell Line: OVCAR3) [5]
Trifluridine + Azacitidine DC24YO8 Azacitidine Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + Azacitidine DCUZG5I Azacitidine Adenocarcinoma (Cell Line: HT29) [5]
Trifluridine + Azacitidine DC6D3FC Azacitidine Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Azacitidine DCPICLB Azacitidine Prostate carcinoma (Cell Line: PC-3) [5]
Trifluridine + Pomalidomide DCTPR02 Pomalidomide Adenocarcinoma (Cell Line: SW-620) [5]
Trifluridine + Mercaptopurine DCSCJV3 Mercaptopurine Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Mercaptopurine DCOYKAI Mercaptopurine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Trifluridine + Taxol DCF8RT0 Taxol Adenocarcinoma (Cell Line: HCT-15) [5]
Trifluridine + Taxol DCROBD9 Taxol High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Trifluridine + Taxol DC6IUIG Taxol Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + FORMESTANE DCNZ4BD FORMESTANE Adenocarcinoma (Cell Line: NCIH23) [5]
Trifluridine + FORMESTANE DCDPMU3 FORMESTANE Adenocarcinoma (Cell Line: HCT116) [5]
Trifluridine + FORMESTANE DC579RX FORMESTANE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Trifluridine + FORMESTANE DCRRNG7 FORMESTANE Lung adenocarcinoma (Cell Line: HOP-62) [5]
Trifluridine + Aminolevulinic Acid Hydrochloride DCR9XCI Aminolevulinic Acid Hydrochloride Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Estramustine DCT39BZ Estramustine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Trifluridine + Estramustine DCLXTJS Estramustine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Trifluridine + Digitoxin DCUB1XH Digitoxin Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Busulfan DCQB2JN Busulfan Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Dasatinib DC34YQM Dasatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Vandetanib + Trifluridine DCK8R5H Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vandetanib + Trifluridine DC8I1CW Vandetanib Colon carcinoma (Cell Line: KM12) [4]
Vandetanib + Trifluridine DCXSGZG Vandetanib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vandetanib + Trifluridine DCZD233 Vandetanib Adenocarcinoma (Cell Line: A549) [5]
Vandetanib + Trifluridine DCHVXK8 Vandetanib Adenocarcinoma (Cell Line: SW-620) [5]
Vandetanib + Trifluridine DCHQBUD Vandetanib Glioma (Cell Line: SF-539) [5]
Vandetanib + Trifluridine DC1KCWA Vandetanib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Vemurafenib + Trifluridine DCHC0IA Vemurafenib Colon carcinoma (Cell Line: KM12) [4]
Vemurafenib + Trifluridine DCYXC1L Vemurafenib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vemurafenib + Trifluridine DC7J3AC Vemurafenib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vemurafenib + Trifluridine DCSIKAE Vemurafenib Adenocarcinoma (Cell Line: NCIH23) [5]
Vemurafenib + Trifluridine DCSIW82 Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vemurafenib + Trifluridine DC7E5LL Vemurafenib Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Vemurafenib + Trifluridine DCW2AW3 Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Vemurafenib + Trifluridine DCO4E7Q Vemurafenib Malignant melanoma (Cell Line: UACC62) [5]
Vemurafenib + Trifluridine DC7XHXM Vemurafenib Melanoma (Cell Line: MALME-3M) [5]
Vemurafenib + Trifluridine DCSOVD1 Vemurafenib Melanoma (Cell Line: UACC-257) [5]
Vismodegib + Trifluridine DCZKBJW Vismodegib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vismodegib + Trifluridine DCBS55V Vismodegib Colon carcinoma (Cell Line: KM12) [4]
Vismodegib + Trifluridine DC7JN0F Vismodegib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vismodegib + Trifluridine DCC2QWF Vismodegib Adenocarcinoma (Cell Line: DU-145) [5]
Vismodegib + Trifluridine DCQJJIJ Vismodegib Adenocarcinoma (Cell Line: A549) [5]
Vismodegib + Trifluridine DC4B8HQ Vismodegib Adenocarcinoma (Cell Line: HCC-2998) [5]
Vismodegib + Trifluridine DCFWY7S Vismodegib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Vismodegib + Trifluridine DCQTNSR Vismodegib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Vismodegib + Trifluridine DCYCK8X Vismodegib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Vismodegib + Trifluridine DC24UAO Vismodegib Malignant melanoma (Cell Line: UACC62) [5]
Vismodegib + Trifluridine DCZZ8U8 Vismodegib Renal cell carcinoma (Cell Line: SN12C) [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 485 DrugCom(s)
1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Trifluridine + TAS-102 DCQKB2S TAS-102 Metastatic Colorectal Cancer [6]
------------------------------------------------------------------------------------

References

1 Trifluridine FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8697).
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
5 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
6 ClinicalTrials.gov (NCT04854434) A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS Mutations